Close

pagibaximab (TAB-H53)

DESCRIPTION CATALOG # SIZE PRICE
Anti-S. epidermidis LTA Recombinant Antibody TAB-H53 1mg Please Inquiry

PRODUCT INFORMATION

  • Product Overview
  • Recombinant Chimeric (human/mouse) antibody to S. epidermidis LTA. Pagibaximab is a chimeric monoclonal antibody for the prevention of staphylococcal sepsis in infants with low birth weight.
  • Type
  • IgG1 - kappa
  • Species Reactivity
  • S. epidermidis
  • Expression Host
  • CHO
  • Applications
  • Suitable for use in FuncS, IF, Neut, ELISA, FC, IP, WB and most other immunological methods.
  • CAS
  • 595566-61-3
  • Specific Activity
  • Staphylococcus epidermidis lipoteichoic acid [Staphylococcus epidermidis]
  • Protein Construction
  • immunoglobulin G1, anti-(Staphylococcus epidermidis lipoteichoic acid)(human-mouse monoclonal heavy chain), disulfide with human- mousemonoclonal κ-chain, dimer
  • Purity
  • >95.0% as determined by Analysis by RP-HPLC & analysis by SDS-PAGE.

BACKGROUND

  • Introduction
  • Lipoteichoic acid (LTA) is a major constituent of the cell wall of Gram-positive bacteria. These organisms have an inner (or cytoplasmic) membrane and, external to it, a thick (up to 80 nanometer) peptidoglycan layer. The structure of LTA varies between the different species of Gram positive bacteria and may contain long chains of ribitol or glycerol phosphate.
  • Keywords
  • Lipoteichoic acid; LTA; S. epidermidis LTA; Staphylococcus epidermidis lipoteichoic acid

Related Products

All listed customized services & products are for research use only, not intended for pharmaceutical, diagnostic, therapeutic or any in vivo human use.

Online Inquiry

Verification code
Click image to refresh the verification code.

CONTACT US

USA: 45-1 Ramsey Road, Shirley, NY 11967, USA
Europe: Heidenkampsweg 58, 20097 Hamburg, Germany
Call us at:
USA: 1-631-381-2994
Europe: 44-207-097-1828
Fax: 1-631-207-8356
Email:
Our customer service representatives are available 24 hours a day, 7 days a week. Contact Us